Viatris (VTRS) Total Debt (2019 - 2026)
Viatris (VTRS) posted Total Debt of $13.4 billion for Q2 2026, down 6.92% on a QoQ basis from $14.3 billion in Q1 2026, and down 7.75% year-over-year from $14.5 billion in Q2 2025.
Analysis
Viatris (VTRS) Total Debt (2019 - 2026) Analysis & Trends
Viatris has reported Total Debt for 8 years, with the latest figure at $13.4 billion in Q2 2026.
- On a quarterly basis, Total Debt fell 7.75% year-over-year to $13.4 billion in Q2 2026; TTM through Jun 2026 was $13.4 billion, a 7.75% decrease from a year earlier, with the FY2025 full-year figure at $14.4 billion, up 2.61% from the prior year.
- Total Debt was $13.4 billion for Q2 2026 at Viatris, down from $14.3 billion in the prior quarter.
- The five-year high for Total Debt was $22.0 billion in Q1 2022, with the low at $13.4 billion in Q2 2026.
- Average Total Debt over 5 years is $17.0 billion, with a median of $17.5 billion recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Debt fell 22.53% in 2024, then rose 2.61% in 2025.
- Over 5 years, Total Debt stood at $19.3 billion in 2022, then decreased by 5.93% to $18.1 billion in 2023, then dropped by 22.53% to $14.0 billion in 2024, then advanced by 2.61% to $14.4 billion in 2025, then declined by 7.37% to $13.4 billion in 2026.
- The last three Total Debt figures came in at $13.4 billion (Q2 2026), $14.3 billion (Q1 2026), and $14.4 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | 16.59 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 13.35 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 813.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | 2.67 Bn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 21.61 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | 1.34 Bn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 301.48 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 612.05 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.35 Bn |
| Mar 31, 2026 | 14.34 Bn |
| Dec 31, 2025 | 14.41 Bn |
| Sep 30, 2025 | 14.44 Bn |
| Jun 30, 2025 | 14.47 Bn |
| Mar 31, 2025 | 14.19 Bn |
| Dec 31, 2024 | 14.05 Bn |
| Sep 30, 2024 | 15.75 Bn |
| Jun 30, 2024 | 17.10 Bn |
| Mar 31, 2024 | 17.97 Bn |
| Dec 31, 2023 | 18.13 Bn |
| Sep 30, 2023 | 18.38 Bn |
| Jun 30, 2023 | 18.60 Bn |
| Mar 31, 2023 | 18.78 Bn |
| Dec 31, 2022 | 19.27 Bn |
| Sep 30, 2022 | 19.99 Bn |
| Jun 30, 2022 | 21.25 Bn |
| Mar 31, 2022 | 22.02 Bn |
| Dec 31, 2021 | 23.09 Bn |
| Sep 30, 2021 | 23.47 Bn |